Literature DB >> 18852285

Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2.

Andre M Pilon1, Murat O Arcasoy, Holly K Dressman, Serena E Vayda, Yelena D Maksimova, Jose I Sangerman, Patrick G Gallagher, David M Bodine.   

Abstract

Erythroid Krüppel-like factor (EKLF) is a Krüppel-like transcription factor identified as a transcriptional activator and chromatin modifier in erythroid cells. EKLF-deficient (Eklf(-/-)) mice die at day 14.5 of gestation from severe anemia. In this study, we demonstrate that early progenitor cells fail to undergo terminal erythroid differentiation in Eklf(-/-) embryos. To discover potential EKLF target genes responsible for the failure of erythropoiesis, transcriptional profiling was performed with RNA from wild-type and Eklf(-/-) early erythroid progenitor cells. These analyses identified significant perturbation of a network of genes involved in cell cycle regulation, with the critical regulator of the cell cycle, E2f2, at a hub. E2f2 mRNA and protein levels were markedly decreased in Eklf(-/-) early erythroid progenitor cells, which showed a delay in the G(1)-to-S-phase transition. Chromatin immunoprecipitation analysis demonstrated EKLF occupancy at the proximal E2f2 promoter in vivo. Consistent with the role of EKLF as a chromatin modifier, EKLF binding sites in the E2f2 promoter were located in a region of EKLF-dependent DNase I sensitivity in early erythroid progenitor cells. We propose a model in which EKLF-dependent activation and modification of the E2f2 locus is required for cell cycle progression preceding terminal erythroid differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852285      PMCID: PMC2593440          DOI: 10.1128/MCB.01087-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Targeting a SWI/SNF-related chromatin remodeling complex to the beta-globin promoter in erythroid cells.

Authors:  C H Lee; M R Murphy; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 2.  Krüppel-like factors: three fingers in many pies.

Authors:  J J Bieker
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

3.  Myc requires distinct E2F activities to induce S phase and apoptosis.

Authors:  G Leone; R Sears; E Huang; R Rempel; F Nuckolls; C H Park; P Giangrande; L Wu; H I Saavedra; S J Field; M A Thompson; H Yang; Y Fujiwara; M E Greenberg; S Orkin; C Smith; J R Nevins
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

Review 4.  Transcriptional regulation of erythropoiesis: an affair involving multiple partners.

Authors:  Alan B Cantor; Stuart H Orkin
Journal:  Oncogene       Date:  2002-05-13       Impact factor: 9.867

Review 5.  Chromatin structure and control of beta-like globin gene switching.

Authors:  Susanna Harju; Kellie J McQueen; Kenneth R Peterson
Journal:  Exp Biol Med (Maywood)       Date:  2002-10

6.  Distinct domains of erythroid Krüppel-like factor modulate chromatin remodeling and transactivation at the endogenous beta-globin gene promoter.

Authors:  R Clark Brown; Scott Pattison; Janine van Ree; Elise Coghill; Andrew Perkins; Stephen M Jane; John M Cunningham
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

7.  Site-specific acetylation by p300 or CREB binding protein regulates erythroid Krüppel-like factor transcriptional activity via its interaction with the SWI-SNF complex.

Authors:  W Zhang; S Kadam; B M Emerson; J J Bieker
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

8.  E2F4 is essential for normal erythrocyte maturation and neonatal viability.

Authors:  P O Humbert; C Rogers; S Ganiatsas; R L Landsberg; J M Trimarchi; S Dandapani; C Brugnara; S Erdman; M Schrenzel; R T Bronson; J A Lees
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

9.  Functional selectivity of recombinant mammalian SWI/SNF subunits.

Authors:  S Kadam; G S McAlpine; M L Phelan; R E Kingston; K A Jones; B M Emerson
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

10.  Sequences downstream of the erythroid promoter are required for high level expression of the human alpha-spectrin gene.

Authors:  Ellice Y Wong; Jolinta Lin; Bernard G Forget; David M Bodine; Patrick G Gallagher
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

View more
  63 in total

1.  A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells.

Authors:  Michael R Tallack; Tom Whitington; Wai Shan Yuen; Elanor N Wainwright; Janelle R Keys; Brooke B Gardiner; Ehsan Nourbakhsh; Nicole Cloonan; Sean M Grimmond; Timothy L Bailey; Andrew C Perkins
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

2.  Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.

Authors:  Mira T Kassouf; Jim R Hughes; Stephen Taylor; Simon J McGowan; Shamit Soneji; Angela L Green; Paresh Vyas; Catherine Porcher
Journal:  Genome Res       Date:  2010-06-21       Impact factor: 9.043

3.  Krüppel-like transcription factors KLF1 and KLF2 have unique and coordinate roles in regulating embryonic erythroid precursor maturation.

Authors:  Divya S Vinjamur; Kristen J Wade; Safa F Mohamad; Jack L Haar; Stephen T Sawyer; Joyce A Lloyd
Journal:  Haematologica       Date:  2014-08-22       Impact factor: 9.941

4.  KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.

Authors:  Graham W Magor; Michael R Tallack; Kevin R Gillinder; Charles C Bell; Naomi McCallum; Bronwyn Williams; Andrew C Perkins
Journal:  Blood       Date:  2015-02-27       Impact factor: 22.113

5.  Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development.

Authors:  Antanas Planutis; Li Xue; Cecelia D Trainor; Mohan Dangeti; Kevin Gillinder; Miroslawa Siatecka; Danitza Nebor; Luanne L Peters; Andrew C Perkins; James J Bieker
Journal:  Development       Date:  2017-02-01       Impact factor: 6.868

Review 6.  Orchestration of late events in erythropoiesis by KLF1/EKLF.

Authors:  Merlin Nithya Gnanapragasam; James J Bieker
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

7.  Erythroid phenotypes associated with KLF1 mutations.

Authors:  Joseph Borg; George P Patrinos; Alex E Felice; Sjaak Philipsen
Journal:  Haematologica       Date:  2011-05       Impact factor: 9.941

Review 8.  EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.

Authors:  Yvette Y Yien; James J Bieker
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

9.  Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.

Authors:  Elizabeth R Macari; Emily K Schaeffer; Rachel J West; Christopher H Lowrey
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

10.  Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin.

Authors:  Joseph Borg; Petros Papadopoulos; Marianthi Georgitsi; Laura Gutiérrez; Godfrey Grech; Pavlos Fanis; Marios Phylactides; Annemieke J M H Verkerk; Peter J van der Spek; Christian A Scerri; Wilhelmina Cassar; Ruth Galdies; Wilfred van Ijcken; Zeliha Ozgür; Nynke Gillemans; Jun Hou; Marisa Bugeja; Frank G Grosveld; Marieke von Lindern; Alex E Felice; George P Patrinos; Sjaak Philipsen
Journal:  Nat Genet       Date:  2010-08-01       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.